An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP)-Reference-Cited by-同舟云学术

An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP)

Published:2017-11 Issue: Volume:113 Page:30-36
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Corrales-Rodríguez Luis,Arrieta Oscar,Mas Luis,Báez-Saldaña Renata,Castillo-Fernández Omar,Blais Normand,Martín Claudio,Juárez Melissa,Khanna Priyanka,Ramos-Esquivel Allan,Bacon Ludwing,Rojas Leonardo,Wills Beatriz,Oblitas George,Pérez María Angelina,Cuello Mauricio,Cardona Andrés Felipe

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference59 articles.

1. Planning cancer control in Latin America and the Caribbean;Goss;Lancet Oncol.,2013

2. Lung cancer in patients younger than 40 years in a multiracial Asian country;Liam;Respirology,2000

3. Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis;Subramanian;J. Thorac. Oncol.,2010

4. Trends and characteristics of young non-Small cell lung cancer patients in the United States;Thomas;Front. Oncol.,2015

5. Clinical and pathological characteristics, outcome and mutational profiles regarding non-small-cell lung cancer related to wood-smoke exposure;Arrieta;J. Thorac. Oncol.,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distant metastatic patterns in young and old non-small cell lung cancer patients: A dose‒response analysis based on SEER population;Heliyon;2024-09

2. Lung cancer and pregnancy;PULMONOLOGIYA;2024-08-18

3. Real-world comprehensive genomic and immune profiling reveals distinct age- and sex-based genomic and immune landscapes in tumors of patients with non-small cell lung cancer;Frontiers in Immunology;2024-06-21

4. Factors Influencing Willingness to Undergo Lung Cancer Screening in the Future: A Cross-Sectional Study of Japanese University Students;Healthcare;2024-04-17

5. The role of angiogenesis inhibitors associated with tyrosine kinase inhibitors in the first-line treatment for EGFR-mutated advanced lung cancer;Critical Reviews in Oncology/Hematology;2024-04